IUP Chapter Meeting in Kyoto
4th Bauerfeind Phlebology Award Won by Dutch Researcher, 06/13/2007
Dutchman Roeland Ceulen, MD, is the winner of the Bauerfeind Phlebology Award, which is jointly awarded by the International Union of Phlebology and Bauerfeind AG for the fourth time this year. With his study design in compression therapy, the winner, a specialist in dermatology, convinced an international jury chaired by Prof. Dr. Hugo Partsch and clearly asserted himself against highly qualified competitors from Slovenia, Poland, France and Switzerland.
The study which the University Hospital, Department of Dermatology in Maastricht proposes to carry out, focuses on the reduction of side and consequential effects of the foam sclerosis of varicose veins. Foam sclerosis of varicose veins is a minimal invasive method which has been applied ever more widely in recent years because it leaves fewer scars and permits quicker rehabilitation. Unlike conventional injection sclerosis, foam sclerosis seems to carry a higher risk of side effects, such as phlebitis and discoloration of skin. The study will look at different possibilities of compression therapy to minimize these side effects or even improve the sclerotic effect. The randomized, controlled study design complies with a high level of evidence and is therefore of high medical quality.
Dr. med. Roeland Ceulen will receive the award trophy and the first installment of the prize money of 20,000 Euro in total during the IUP Chapter Meetings in Kyoto from June 18th to 20th, 2007. He will give a talk on his study project there on June 19th. The second installment will be paid out to the prize winner if he presents the work according to the study design within the next 18 months.
Research projects in the field of compression therapy have been supported by Bauerfeind for years. As one of the leading manufacturers of compression stockings, this company encourages the development of innovative products and systems which meet the constantly growing demands of patients and attending doctors for optimal treatment.
